Skip to main content
Scienza Health
COMPARISON

Cognitive Screening Tools Compared for Skilled Nursing Facilities

MMSE, MoCA, BIMS, SLUMS, and multimodal voice biomarker screening side by side

Skilled nursing facilities screen for cognitive impairment using standardized tools that were designed decades ago for one-on-one clinical encounters. The MMSE takes 10 to 15 minutes. The MoCA takes 10 to 15 minutes. The BIMS is faster at 3 to 5 minutes but screens only for cognitive function and misses behavioral and neurological conditions entirely. Each requires a trained staff member to administer, score, and document. A 450,000-nurse shortage in post-acute care means most facilities cannot sustain that at the frequency residents need. GIA® by Scienza Health screens for 46 conditions across cognitive, behavioral, and neurological categories in a single conversation lasting 40 seconds. Zero clinical staff required. Results are prepared for clinician review and submission to the EHR.

HEAD TO HEAD

How do they compare?

DimensionTraditional Cognitive Screening (MMSE, MoCA, BIMS, SLUMS)GIA™
Time to screen10-30 minutes per tool40 seconds total
Staff requiredLicensed clinician for full durationZero during screening
Conditions screened1 per tool (cognitive only)46 across cognitive, behavioral, neurological
DocumentationManual scoring + manual EHR entryAutomated notes, CPT codes, session video
Clinician reviewClinician administers and scoresClinician reviews prepared results in under 2 minutes
Clinical validationManual scoring; varies by toolPeer-reviewed speech biomarker science across 19 studies
LanguagesEnglish (some translated versions)92 languages with English EHR transcription
EHR integrationManual data entryPointClickCare, Epic, Cerner, MatrixCare via HL7 FHIR
Annual staff time (120-bed facility)Thousands of hoursRecovers up to 240 hours per year
TRADITIONAL COGNITIVE SCREENING (MMSE, MOCA, BIMS, SLUMS)

Where traditional cognitive screening (mmse, moca, bims, slums) falls short

Standardized pen-and-paper or interview-based assessments administered by a licensed clinician. Each screens for cognitive function within a single clinical category.

  • MMSE and MoCA each take 10 to 15 minutes per patient per assessment
  • BIMS is faster (3 to 5 minutes) but has limited sensitivity for mild cognitive impairment
  • Each tool screens for one condition category. Depression, anxiety, PTSD, and movement disorders require separate assessments
  • Every assessment requires a trained staff member for the full duration
  • A 450,000-nurse shortage means screenings are administered infrequently or skipped entirely
  • MMSE is copyright-restricted and requires licensing fees
  • Manual scoring and documentation add 5 to 10 minutes per assessment
GIA™

What GIA™ does differently

  • Screens for 46 cognitive, behavioral, and neurological conditions in a single conversation
  • 40 seconds per screening with results in under 2 minutes
  • Zero clinical staff required during the screening conversation
  • 2,500+ speech biomarkers analyzed alongside computer vision
  • Structured medical notes, CPT codes, and session video prepared for clinician review
  • Peer-reviewed validation from academic medical centers, and The Lancet (19 published studies)
  • Live on the PointClickCare Marketplace. Integrates with Epic, Cerner, and MatrixCare via HL7 FHIR
  • In a 120-bed facility, replaces up to 240 hours of staff screening time per year
THE BOTTOM LINE

Traditional cognitive screening tools were built for clinical research settings with adequate staffing. Post-acute care in 2026 does not have adequate staffing. The question is not whether the MMSE or MoCA is a good assessment. It is whether a 120-bed facility with 60% of the nurses it needs can administer it consistently across the census. GIA® by Scienza Health replaces that operational bottleneck with a screening conversation that requires zero staff, covers 46 conditions, and prepares everything for clinician review.

WHY GIA® GOES FURTHER

Beyond the comparison

GIA® pairs every screening encounter with PDO — Proactive Decision Orders — a nightly EHR analysis layer that surfaces ranked clinical recommendations for physician review. No competing platform offers population-level decision support alongside point-of-care screening.

GIA® is trained on a dataset of 12.3M+ patients and 27B+ clinical records, validated across 19 peer-reviewed studies by independent researchers at academic medical centers.

FREQUENTLY ASKED QUESTIONS

Common questions

Is GIA® a replacement for the MMSE or MoCA?

The MMSE and MoCA are validated cognitive assessments with decades of clinical use. GIA® by Scienza Health is not a replacement for clinical judgment. She screens for 46 conditions using voice biomarkers and computer vision, then prepares structured results for the clinician. The clinician reviews, decides, and submits. GIA® changes who does the screening, not who makes the clinical decision.

How does GIA® accuracy compare to traditional cognitive assessments?

Peer-reviewed accuracy for GIA® by Scienza Health: Depression AUC 0.874, PTSD AUC 0.907, Anxiety AUC 0.884, Parkinson’s AUC 0.97. Traditional tools like the MMSE and MoCA have high sensitivity for moderate-to-severe impairment but lower sensitivity for mild cognitive impairment. GIA® screens across cognitive, behavioral, and neurological categories simultaneously. 19 peer-reviewed speech biomarker studies in major medical journals.

Does GIA® require clinical staff to administer the screening?

No. GIA® by Scienza Health conducts the screening conversation independently. She greets the resident, adapts to their pace and language, and captures 40 seconds of speech for biomarker analysis. Computer vision runs simultaneously. No clinician is present during the conversation. The clinician reviews the prepared results afterward in under two minutes and decides what action to take.

What regulatory oversight does GIA® have compared to the MMSE?

The MMSE, MoCA, BIMS, and SLUMS are paper-based assessment tools with no software-level regulatory oversight or independent peer-reviewed AI validation. GIA® by Scienza Health is peer-reviewed across 19 published studies by independent researchers at academic medical centers, and The Lancet — including cognitive decline at AUC 0.890 and Parkinson's at AUC 0.97. Additionally, GIA® maintains HIPAA compliance, a SOC 2 Type II audit in progress, and AES-256 encryption. Quarterly bias audits are conducted across age, gender, race, and language.

Can GIA® screen for conditions beyond cognitive impairment?

Traditional tools screen for one category each: the MoCA for cognitive decline, the PHQ-9 for depression, the GAD-7 for anxiety. GIA® by Scienza Health screens across all three categories plus neurological conditions in a single conversation. 46 conditions total including Alzheimer’s, MCI, depression, PTSD, Parkinson’s, tardive dyskinesia, burnout, and substance use indicators. One conversation. One clinical package for review.

MORE COMPARISONS
GIA® vs. Manual Clinical ScreeningWhat changes when you stop screening with clipboards and start screening with speech biomarkersGIA® vs. Traditional Cognitive AssessmentMoCA, MMSE, and BIMS were designed for a world with enough staff and enough time. That world does not exist in post-acute care.Digital Human® vs. ChatbotOne screens for 46 clinical conditions from speech biomarkers. The other answers questions from a script.GIA® vs. Linus HealthCognitive assessment is one domain. Clinical screening across 46 conditions is a different category entirely.GIA® vs. CogstateGame-based cognitive testing was built for clinical trials. Conversational multimodal screening was built for clinical care.Cognitive Assessment: Multimodal Screening vs. Eye-TrackingTwo approaches to cognitive health. Different modalities, different clinical settings, different condition coverage.Clinical Screening: Multimodal Voice Biomarkers vs. Tablet-Based TestingTwo approaches to cognitive assessment in clinical settings. Different modalities, different workflows.Voice Biomarker AI: See How GIA® Stacks UpA comprehensive comparison of voice biomarker platforms for clinical screening.Your EAP Exists. 95% of Employees Never Use It.GIA® is the screening layer that catches what traditional EAP intake misses and routes employees into your program.GIA® vs. CognivueAn FDA-cleared cognitive test on a dedicated device is one tool. Multimodal screening across 46 conditions in a conversation is another.GIA® vs. Cambridge Cognition (CANTAB)Research-grade computerized test batteries and point-of-care conversational screening were built for two different rooms.
FREE GUIDE

The Operator's Guide to Multimodal Clinical AI

What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.

See the difference live

Watch GIA™ screen a patient in 40 seconds.

Schedule a Demo